Liraglutide trumps orlistat in obesity trial
Links shared publicly online about this topic.
- 1,657total visits
Liraglutide trumps orlistat in obesity trial
A drug originally developed to treat diabetes may have promise as an obesity therapy, a new study shows. Those taking liraglutide, a GLP-1 analog, lost more weight than those on an established obesity medication, orlistat.
View full resource at theheart.org
Tags: Diabetes, Diabetes Type 2 Medication, Obesity, Obesity Medication, Drug, Xenical, Victoza
Most Recently Shared on October 23, 2009 at 12:12 am By:
heartwire: GLP-1 analog liraglutide promising in obesity http://bit.ly/gK1Dv
Liraglutide trumps orlistat in obesity trial
m.theheart.org — “A drug originally developed to treat diabetes may have promise as an obesity therapy, a new study shows. Those taking liraglutide, a GLP-1 analog, lost more weight than those on an established obesity medication, orlistat.” View full resource at m.theheart.org
Most Recently Shared on October 23, 2009 at 1:26 am By:
heartwire: GLP-1 analog liraglutide promising in obesity http://bit.ly/2Wv2G4
Advertisement
